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Building associated illnesses – sick building syndrome (SBS) as a common example – are associated with 
staying in buildings with poor indoor air quality. The importance of indoor fungal growth in this phenomenon 
continues to be evident, even though no causative relation has been established so far. Indoor humidity is 
strongly associated with the symptoms of SBS. Fungal metabolites that may induce ill health in susceptible 
occupants comprise beta-D-glucan, mycotoxins, and volatile organic compounds as known irritants and/or 
immunomodulators. Indoor toxic fungal metabolites might be located in micromycetal propagules 
(endometabolites), in (bio-)aerosol, detritus, and house dust (exometabolites) as their particular carriers. 
It is highly probable that hyphal fragments, dust, and particles able to reach the alveoli have the strongest 
depository and toxic potential. Most fungal spores are entrapped by the upper respiratory tract and do not 
reach further than the bronchi because of their size, morphology, and the mode of propagation (such as 
slime heads and aggreggation). This is why studies of the toxic effects of fungal spores prefer directly 
applying metabolite mixtures over mimicking real exposure. Chronic low-level exposure to a mixture of 
fungal toxicants and other indoor stressors may have synergistic effects and lead to severe neuroendocrine-
immune changes.
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Different indoor factors (such as chemicals, 
microorganisms, allergens, and tobacco smoke) can 
contribute to many building-related illnesses (BRI) in 
exposed occupants. These include infections related 
to building ventilation (legionellosis), common cold, 
ﬂ u or, reactions to indoor chemicals, fungi, bacteria, 
and/or their toxins. A type of BRI known as sick 
building syndrome (SBS) includes a complex of health 
complaints and general discomfort (1, 2). Symptoms 
of SBS are non-speciﬁ c and usually depend on indoor 
microclimatic parameters such as temperature, relative 
humidity, dust, cigarette smoke, ventilation, building 
materials and furnishing, and sensibility of affected 
persons. Inﬂ ammatory reactions to indoor toxicants 
are either local – in the airways, mediated by IgE 
(allergic mechanism) or by non-speciﬁ c inﬂ ammation 
(e. g. cytotoxic effects) – or systemic through the 
release of lung cytokines (3). The role of fungi in the 
aetiology of health problems associated with staying 
in certain buildings has not been fully clariﬁ ed. Indoor 
fungal exposure may lead to allergies such as fungal 
rhinitis, hypersensitivity pneumonia, and/or asthma 
(4, 5). Monitoring exposure to indoor fungi is rather 
complicated due to a lack of standard methods to 
evaluate how indoor microclimate, outdoor 
environment, and microscopic fungi affect each other. 
The ability of Penicillium sp. and Aspergillus sp., the 
so-called ﬁ rst colonisers, to grow on common house 
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dust at relative humidity of 76 % to 80 % can probably 
explain why they prevail even in healthy buildings. 
Secondary colonisers (Cladosporium sp., Alternaria 
sp., Chaetomium sp.) that grow at 85 % relative 
humidity and tertiary colonisers (Fusarium sp., 
Acremonium sp., yeasts) that grow at >90 % humidity 
are able to biodeteriorate any building material under 
optimal growth conditions (6-8).
MYCOTOXINS, VOLATILES, AND 
HAEMOLYSINS
Currently, a general approach to the study of the 
mechanism of fungal effects on human beings is 
becoming more urgent. Such an approach includes the 
immunosuppressive inﬂ uence and (bioaerosoloic) 
inﬂ ammatory reactions to beta-glucans from fungal 
cell wall as well as toxic and irritative effects of their 
toxic exo- and endometabolites – mycotoxins and/or 
volatile organic compounds, and pathological 
conditions associated with fungal haemolysins (9). 
Regarding mycotoxins with rather well characterised 
toxicity (incl. carcino-, muta-, teratogenicity, 
cytotoxicity and immunosuppression) after ingestion 
or dermal exposure, an adverse biological effect can 
be caused by the inhalation of a dose at the minimum 
level of one tenth of the alimentary one. Indoor 
mycotoxins and their health effects have joined the 
most studied public health issues (10).
Microbial volatile organic compounds (MVOCs) 
such as alcohols, aldehydes, ketones, aromatic 
compounds,  amines,  terpenes,  chlorinated 
hydrocarbons, and sulphuric compounds, (at indoor 
concentrations as high as 250 mg m-3) cause typical 
mouldy odour (usually 2-octen-1-ol or geosmine), but 
also an irritation, swelling/inﬂ ammation of the airways 
in sensitive people, and/or cytotoxic effects (DNA 
damage). These effects are associated with invisible 
moulds usually growing under wallpaper, carpets, or 
mattresses. The most common MVOCs are xylene, 
toluene, 2-propanol, limonen, heptane, formaldehyde, 
and acetaldehyde. There is a positive correlation 
between MVOC production and the ability of fungi 
to synthesise mycotoxins. According to Larsen et al. 
(11) and Corpi et al. (12), Aspergillus spp., A. 
versicolor, Cladosporium spp. and Penicillium spp. 
are the strongest producers of such compounds, e. g. 
2-ethylhexanol, cyclohexane (skin and/or mucose 
irritation), and carcinogenic benzene.
Although, many occupational pulmonary 
mycotoxicoses have been reported as adverse effects 
of inhaled organic dust contaminated by microbial 
toxins (13), there is no objective evidence of clinical 
diseases caused by indoor mycotoxins alone, produced 
by Aspergillus sp., Penicillium sp., Fusarium sp., 
Trichoderma sp. and Stachybotrys chartarum, as no 
serious epidemiological study has addressed the issue 
(14). During the fatal infant idiopathic pulmonary 
haemorrhage outbreaks in the USA, isolated fungi 
were analysed for toxicity in vitro. S. chartarum 
produced cytotoxic and immunosuppressive 
macrocyclic trichothecenes (stachybotryotoxins) and 
spirocylic drimanes that caused inﬂ ammation and 
haemorrhages in the respiratory tract and intestines of 
laboratory animals. M. echinata produced griseofulvins 
and A. versicolor carcinogenic sterigmatocystin (15). 
Toxins produced by stachybotrys (satratoxins, roridins, 
verrucarins) affect the cell by binding to 60S 
ribozomes, by inhibiting proteosynthesis, elongation, 
termination, and by inducing apoptosis, as they induce 
mitogen-activating proteinkinases (MAPK). Hintikka 
(16) also found that spirocyclic drimans of S. 
chartarum inhibited proteosynthesis and were 
immunosuppressive (inhibited the complement system 
and TNF-alfa release and stimulated plasminogen, 
ﬁ brinolysis, and thrombolysis). Tobacco smoke was 
stressed by some epidemiologists as increasing the 
health risk of fungal toxins (14). S. chartarum isolated 
cardboard and vinyl ceilings of damp schools and 
dwellings in Denmark produced trichodermol 
trichothecenes (17). Acute intratracheal exposure of 
rats to atranone A, produced by S. chartarum isolated 
from mouldy walls in a Bratislava house, resulted in 
haematological changes, cell damage, and inﬂ ammatory 
pulmonary injury in those animals (18, 19). However, 
complex toxic mechanisms underlying the in vivo 
activity of atranones remain unclear. Simple 
trichothecens (such as trichodermol and trichodermin) 
that usually accompany atranones are neurotoxic (eye 
dysfunction, dyspnoea, tachycardia, nausea, tremors, 
dizziness, lowered concentration, confusion, loss of 
balance, hypotension, myelosupression, lower CNS 
activity bordering neurocognitive/behavioural deﬁ cits, 
and somnolence) and act as skin irritants (20).
In mice, Ren et al. (21) reported the adverse effects 
of mutagenic and foetotoxic mycotoxin alternariol and 
its monomethylether produced by Alternaria alternata 
isolated from ceiling tiles. This isolate was also able 
to grow on cardboard. An experimental culture of 
Penicillium expansum grown on wallpaper glue 
produced nephrotoxic citrinin and fagocytosis-
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inhibiting patulin (22). Metabolite synthesis in fungi 
depends on the quality of construction materials (23, 
24). In our earlier study (25) on tracheal cultures of 
1-day-old chicks, varying ciliostatic activity was found 
in biomass extracts from building materials (mineral 
wool, plasterboard, cardboard) inoculated with pure 
isolates of indoor moulds Penicillium chrysogenum, 
P. palitans, Trichoderma viride, Stachybotrys sp., and 
A. versicolor. Generally, moulds growing on materials 
composed of ﬁ nely divided cellulose were more active 
than those growing on mineral wool. The only 
available data on the ciliostatic activity of indoor 
mould metabolites refer to sterigmatocystin from A. 
versicolor and Chaetomium spp. even though 78 % 
of all indoor fungi (Aspergillus clavatus, A. ﬂ avus, A. 
fumigatus, A. nidulans, A. niger, A. ochraceus, A. 
restrictus, A. ustus, A. versicolor, Alternaria sp., 
Chaetomium sp., Cladosporium cladosporioides, C. 
sphaerospermum, Phoma sp., and Stachybotrys 
chartarum) isolated in Slovakia over the last 15 years 
produce complex metabolites capable of stopping 
tracheal ciliary beating in 24 hours (26-28). Viable 
spores of A. versicolor and Penicillium sp. were 
isolated from different plasters after 40 days to 3 
months (7, 8), which means that they are able to 
produce toxins for a relatively long time.
Only a few animal studies addressed histological 
pulmonary changes after intranasal exposure to fungal 
spores and the time course of inflammatory and 
cytotoxic processes in the airways after intratracheal 
instillation of sporal suspensions (20, 29, 30). All toxic 
fungal metabolites are located in micromycetal 
propagules (endometabolites), in aerosol, detritus, and 
house dust (exometabolites) (6). It is highly probable 
that hyphal fragments, dust, and material particles able 
to reach the alveoli have the highest depository and 
toxic potential. Most of the fungal spores are entrapped 
by the upper respiratory tract and do not reach further 
than the bronchi, because of their size, morphology, 
and the mode of propagation (slime heads, aggregation, 
etc.). This is why studies of the toxic effects of fungal 
spores prefer direct use of metabolite mixtures over 
recreating real exposure to microorganisms.
Health damaging effects of fungal haemolysins 
(indoor e. g. stachylysin produced by S. chartarum,or 
chrysolysin by Penicillium chrysogenum) result from 
the activation of histamine- and cytokin-producing 
cells (inﬂ ammatory, cold-like SBS symptoms) and 
from vascular tissue lysis (headaches, bleeding, 
vertigo) (31).
CONCLUSIONS
In the occupants of damp mouldy dwellings, 
complex toxic fungal metabolites can disrupt the self-
cleaning airway system, induce inﬂ ammation, and 
damage cells and blood. These effects are enhanced 
by indoor contaminants such as cigarette smoke and 
can ﬁ nally result in ill health including respiratory 
disorders and general intoxication, especially in 
children with quick metabolism. To determine the 
relationship between mycotoxins, their real mixtures, 
and other bio-, and non-biological factors in indoor 
environment and speciﬁ c human health disorders after 
their inhalation, it is necessary to establish the minimal 
effective concentration of mycotoxin able to cause 
clinical symptoms, as opposed to the in vitro approach, 
to choose the best animal or other biological model 
for studying mycotoxin pathogenicity and 
pathophysiology (pulmonary deposition), and to 
characterise short- and long-term health damages 
(biomarkers) in the exposed people. Future studies 
should not neglect the potential of fungal toxins to 
cause multifactorial human diseases (immune, 
degenerative, and tumorous), whose incidence and 
prevalence are on the rise in modern societies.
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Sažetak
ŠTETNI ZDRAVSTVENI UČINCI PLIJESNI UNUTARNJIH PROSTORA
Bolesti povezane sa stanovanjem te sindrom bolesne zgrade (engl. sick building syndrome, SBS), kao jedan 
od njihovih tipičnih primjera, povezani su s boravkom u zgradama s lošom kvalitetom zraka. Premda još 
nije uspostavljena jasna uzročno-posljedična povezanost, važnu ulogu u spomenutom fenomenu ima rast 
plijesni u unutarnjim prostorima. Pojavnost simptoma sindroma bolesne zgrade snažno ovisi o vlažnosti 
prostora. U metabolite plijesni koji mogu izazvati poremećaje zdravlja u osjetljivijih ispitanika ubrajamo 
beta-D-glukan, mikotoksine te hlapljive organske spojeve koji su poznati kao iritansi i/ili imunomodulatori. 
Toksični metaboliti gljiva unutarnjih prostora mogu biti sadržani u propagulama mikromiceta 
(endometaboliti), (bio)aerosolu, detritusu te kućnoj prašini (egzometaboliti). Najjači potencijal za depoziciju 
te toksični potencijal imaju fragmenti hifa, prašina i čestice koje mogu doprijeti do alveola. Većinu gljivičnih 
spora zaustave gornji dišni putovi te one zbog svoje veličine, morfologije i načina razmnožavanja (npr. 
ljepljive glavice i agregacija) ne dopiru dalje od bronha. To je razlog zašto se u istraživanjima toksičnih 
učinaka gljivičnih spora češće primjenjuju smjese metabolita negoli oponaša stvarna izloženost. Kronična 
izloženost niskim razinama smjesa gljivičnih toksikanata i drugih stresora unutarnjih prostora može izazvati 
sinergijske učinke i dovesti do teških neuroendokrino-imunosnih promjena.
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